AFP and hepatocellular carcinoma: In addition, the combination of miRNA-122, miRNA-148a, and Alpha-fetoprotein (AFP) increases diagnostic accuracy (AUC:0.931, 95% CI, 0.857–0.973), suggesting that the serum vesicle microRNA signature alone or in combination with available markers could be used as a screening tool for HCC [83].